Guidelines
Without comorbidities
With comorbidities
Recommendations
Western guidelines
National Institute of Health
BMI ≥40
BMI ≥35
Should be considered
Obesity Surgery Society of Australia and New Zealand
BMI >40
BMI ≥35
Should be considered
American Society for Metabolic & Bariatric Surgery
BMI ≥40
BMI ≥35
BMI ≥30
Should be considered
May also be offered
International Federation for the Surgery of Obesity: European Chapter
BMI ≥40
BMI ≥35
Should be considered
Asian guidelines
Asia Pacific Metabolic and Bariatric Surgery Society
BMI >37
BMI ≥32 with DM or two co-morbidities
Should be considered
Asian Consensus Meeting of Metabolic Surgery
BMI ≥35
BMI ≥32
BMI ≥30 Central obesity + 2 metabolic
BMI <30
Strictly under study protocol
Should be considered
Should be considered
International Federation for the Surgery of Obesity: Asia Pacific Chapter
BMI ≥35
BMI ≥30
BMI ≥27.5 with inadequately controlled DM
BMI <27.5 with inadequately controlled DM
Strictly under study protocol
Should be considered
May be considered
Medical association guidelines
The International Diabetes Federation
–
BMI ≥35 with DM **(Asian −2.5)
BMI 30–35 with inadequately controlled DM
Alternative treatment
Accepted option
Diabetes Surgery Summit
–
BMI ≥35
BMI 30–35
Should be considered
May also be appropriate
Asian Diabetes Surgery Summit
BMI ≥37
BMI ≥32 with DM (HbA1c >7.5)
BMI ≥27 with many co-morbidities
Related posts:
Preoperative Evaluation and Contraindications to Bariatric Surgery
Gastroesophageal Reflux and Bariatric Surgery
Perioperative Management of Medical Comorbidities After Bariatric Surgery
Management of Leaks After Sleeve Gastrectomy
Management of Leaks After Gastric Bypass
Importance of Protein After Bariatric Surgery
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access
